Navigation Links
Drug for Deadly Lung Disease Shows Promise
Date:5/23/2008

Idiopathic pulmonary fibrosis kills 40,000 Americans each year

FRIDAY, May 23 (HealthDay News) -- Patients with a progressive fibrosis of the lungs that's fatal within a few years of diagnosis may finally have some reason for hope.

Japanese researchers say daily use of the drug pirfenidone improved the lung function and lengthened the survival of patients with the illness, called idiopathic pulmonary fibrosis (IPF).

"Patients look to any research in IPF with a sense of hope, because right now, there's very little that can be done for them," said Mark Shreve, founder and chief operating officer of the Coalition for Pulmonary Fibrosis, based in San Jose, Calif.

"To say that there's a desperate need -- even that would be an incredible understatement, because you are talking about a devastating, relentless disease that has a survival rate of less than three years, and no proven cause and no treatment," he said.

But the results of the new phase III clinical trial, involving 275 Japanese patients with mild-to-moderate IPF, may change all that. The findings were presented this week at the annual meeting of the American Thoracic Society, in Toronto.

According to Shreve, 128,000 Americans are battling IPF at any given time. Each year, 48,000 new cases are diagnosed, and 40,000 people die from the illness -- equal to the annual death toll from breast cancer.

IPF's origins remain largely unknown. It typically arises in late middle-age or the senior years and involves a progressive fibrosis: a process in which healthy lung tissue turns into useless scar tissue. This hardening of the lungs gradually and relentlessly robs patients of their ability to breathe.

"There's no drug, period, that's ever been approved for IPF," Shreve said. "Right now, the only treatment option that's been shown to extend the lives of patients is a lung transplant. But, other than that, the disease itself is an
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. World Vision Appealing for $2 Million for Deadly China Quake
2. Melanomas on Scalp and Neck More Deadly
3. Study sheds light on deadly lung disease
4. Infection Experts Report Reveals the CDCS Deadly Mistakes
5. Stopping a deadly killer
6. Deadly disease eliminated in children under 5 years of age in Uganda
7. Mother-daughter conflict, low serotonin level may be deadly combination
8. Researchers find possible target to treat deadly bloodstream infections
9. Heart Attacks in Hospital More Deadly at Night, on Weekends
10. Choking Game Turned Deadly for 82 Youths
11. Mutual Resentment in Marriage Can Be Deadly
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... By Kathleen Doheny ... (HealthDay News) -- Birth control pills containing high doses ... the risk of breast cancer in women under 50, ... oral contraceptive formulations," explained lead researcher Elisabeth Beaber, a ... in Seattle. "Some of these formulations increase breast cancer ...
(Date:8/1/2014)... Roaming the high Alps more than 5,000 years ago, ... Man" no doubt had a very tough and active lifestyle. ... the Ice Man, nicknamed Otzi, from a very modern scourge: ... "hardening of the arteries," appears to be the same today ... finds. "Our ancestors going back thousands of years ...
(Date:8/1/2014)... The European gas chromatography systems report defines ... forecast of revenue. The gas chromatography systems market in Europe ... to grow to around $247.6 million by 2018, at a ... the TOC of the European gas chromatography systems market, to ... provides a glimpse of the segmentation of gas chromatography systems ...
(Date:8/1/2014)... to a new market research report of "Thermocouples and ... (Automotive, Petrochemical, Consumer Utility, Glass, and Aerospace & Defense) ... & Forecast to 2010 - 2020", published by MarketsandMarkets, ... Billion by 2020 at a CAGR of 3.70% and ... $238.17 Million by 2020 at a CAGR of 13.81% ...
(Date:8/1/2014)... The Gerontological Society of America (GSA) ... the field of aging has chosen J. ... 2014 recipient of the Distinguished Career Contribution to ... annually to an individual whose theoretical contributions have ... or have yielded original and elegant research designs ...
Breaking Medicine News(10 mins):Health News:Some Birth Control Pills May Up Breast Cancer Risk 2Health News:Some Birth Control Pills May Up Breast Cancer Risk 3Health News:'Ice Man' Mummy May Have Been at Risk of Heart Disease 2Health News:European Gas Chromatography (GC) Systems Market is Expected to Reach $247.6 Million in 2018 - New Report by MicroMarket Monitor 2Health News:European Gas Chromatography (GC) Systems Market is Expected to Reach $247.6 Million in 2018 - New Report by MicroMarket Monitor 3Health News:European Gas Chromatography (GC) Systems Market is Expected to Reach $247.6 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Thermocouples Market worth $1.42 Billion & High End Optical Pyrometers Market worth $ 238.17 Million by 2020 2Health News:Thermocouples Market worth $1.42 Billion & High End Optical Pyrometers Market worth $ 238.17 Million by 2020 3Health News:Thermocouples Market worth $1.42 Billion & High End Optical Pyrometers Market worth $ 238.17 Million by 2020 4Health News:Suitor to receive GSA's 2014 Distinguished Career Contribution to Gerontology Award 2
... VIEW, Calif., Nov. 20 Omnicell, Inc. (Nasdaq: OMCL ) a ... company will present at the 21st Annual Piper Jaffray Healthcare Conference ... , Omnicell Speakers: Randall A. Lipps, founder, chairman, president & ... Tuesday, December 1, 2009 , Time: 1:00 p.m. EST , ...
... , NEW YORK, Nov. 20 Today, ... announce the launch of a capsule gift giving collection offered exclusively ... is inspired by and designed for St. Jude,s Children,s Research Hospital,s ... program which encourages consumers to "give thanks for the healthy kids ...
... DEL REY, Calif., Nov. 20 Heritage Provider Network, and its ... November 6, 2009, Lakeside Medical Systems, Inc., as well as all ... of the HPN family. , "We first and foremost want to ... are dedicated to maintaining the high level of care they are ...
... ... the national healthcare network, to deliver multispecialty physicians for locum tenens (temporary substitute) ... ... Healthcare is pleased to announce its agreement with VHA Inc., the national healthcare ...
... , NEW ... new market research report is available in its ... Market Review , http://www.reportlinker.com/p0164325/Imaging-Agents---A-Worldwide-Market-Review.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire ... visualization of organs within the human body. With ...
... , Carrying and Lifting Tips to Keep you Injury-free this ... travelers have a saying - " Pack your bags, then take out ... bring much more than we need on our trips. Now, even ... are charging passengers a fee for checking luggage . However, ...
Cached Medicine News:Health News:Omnicell to Present at Piper Jaffray Healthcare Conference 2Health News:DKNY JEANS Launches Exclusive Collection With HSN for St. Jude Children's Research Hospital's Thanks and Giving(R) Campaign 2Health News:DKNY JEANS Launches Exclusive Collection With HSN for St. Jude Children's Research Hospital's Thanks and Giving(R) Campaign 3Health News:Heritage Provider Network CEO Dr. Richard Merkin, Announces the Acquisition of Lakeside Medical Systems, Inc. 2Health News:Heritage Provider Network CEO Dr. Richard Merkin, Announces the Acquisition of Lakeside Medical Systems, Inc. 3Health News:VHA Names Jackson Healthcare as Preferred Physician Staffing Vendor 2Health News:VHA Names Jackson Healthcare as Preferred Physician Staffing Vendor 3Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 2Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 3Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 4Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 5Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 6Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 7Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 8Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 9Health News:This Thanksgiving, Lug your Luggage Safely 2Health News:This Thanksgiving, Lug your Luggage Safely 3
(Date:7/31/2014)...  Cepheid (NASDAQ: CPHD ) today announced that ... invited investors to participate via webcast. ... NY Wednesday, August 13, 2014 at 9.10 a.m. ... New York, NY Thursday, September 4, 2014 ... Webcasts To access the live webcasts for these events, please ...
(Date:7/31/2014)... , July 31, 2014 Rock Creek ... that it has initiated the development of its lead ... and that it has selected Quotient Clinical, The Translational ... (UK) to run its early development programs. ... Trial Application (CTA) by the end of the third ...
(Date:7/31/2014)... , July 31, 2014 Lazarus Effect, a ... interventional devices to facilitate removal of blood clots, announced ... the financing will support EU commercialization of several approved ... the Lazarus ReCover™ and Lazarus Cover™ in ... reflects investor confidence in the value of our novel, ...
Breaking Medicine Technology:Cepheid to Webcast Upcoming Financial Presentations 2Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 2Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 3Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 4Lazarus Effect Closes $5 Million Financing 2
... SAN DIEGO, Jan. 31 TargeGen, Inc. ... multi-center Phase I/II clinical trial of,TG101348, an ... JAK2 in,patients with myeloproliferative diseases., (Logo: ... of JAK2 is implicated in the pathogenesis ...
... Mayo clinic in key role in treatment discovery, ... New York,based company Cytopia Limited (ASX: CYT) announced ... demonstrated potent activity in cells,isolated from patients with ... of diseases where there is over-production of,particular cells ...
Cached Medicine Technology:TargeGen Announces Initiation of Clinical Trial of JAK2 Inhibitor TG101348 in Myeloproliferative Disease Patients 2JAK2 Inhibitor Shows Potent Activity in Cells From MPD Patients 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: